Phase II Trial of SPECT-Guided Functional Lung Avoidance Radiation Therapy
for Patients With Lung Cancer Receiving Curative Chemo-Radiotherapy
Led by University of Aarhus · Updated on 2026-02-24
90
Participants Needed
2
Research Sites
52 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating a new method called functional lung avoidance radiotherapy for patients with advanced lung cancer undergoing chemo-radiotherapy. This approach uses a special imaging scan called perfusion single photon emission SPECTCT to identify and protect highly functional areas of the lung from radiation. The study aims to see if this method improves lung toxicity outcomes compared to standard radiation therapy.
Participants receive either SPECT-based radiation therapy that avoids highly functional lung areas or standard CT-based radiation therapy over 5 to 6.5 weeks. Both treatments are given with curative intent and may be combined with chemotherapy. The trial is randomized and includes a comparison between the new functional avoidance approach and the usual radiation treatment.
During the study, participants will be monitored for lung toxicity from 1 to 12 months after treatment. Researchers will also assess quality of life, lung symptoms reported by patients, cancer progression, survival, and tumor control. Follow-up includes regular evaluations to track these outcomes and compare the effects of the two radiation approaches over one year.
CONDITIONS
Brief Title
Functional Lung Avoidance SPECT-guided Radiation Therapy of Lung Cancer
Research Team
K
Katherina Farr, MD PhD FRACP
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Westmead and Blacktown Hospital, Sydney West Radiation Oncology Network, Sydney, Australia
Collaborating Sponsor
Who Can Participate
Age: 18Years +
All Genders
Eligibility Criteria
You may qualify if you...
Histologically confirmed lung cancer (small-cell or non-small cell)
Planned for curative radiotherapy, including doses of 60-66 Gy in 2-Gy fractions or as per site standard
Concurrent chemotherapy allowed
Patients with limited metastases treated with surgery or radiotherapy allowed
Adults aged 18 years or older
Provided oral and written informed consent before registration
You will not qualify if you...
Receiving immunotherapy during the study
Previous radiotherapy to the chest area
Other uncontrolled cancers
Psychological, familial, social, or geographic conditions that may prevent following the study protocol
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Treatment
Duration - 5 to 6.5 weeks
Participants receive radiation therapy for lung cancer. Those in the experimental group receive SPECT-based radiation therapy that avoids highly functional lung areas, while others receive standard CT-based radiation therapy over 5 to 6.5 weeks. Concurrent chemotherapy may be given as part of treatment.
Radiation therapy sessions over 5 to 6.5 weeks
Follow-up
Duration - 1 to 12 months after treatment completion
Participants are monitored for radiation-induced lung toxicity, quality of life, lung symptoms, progression, and survival after treatment completion.
Regular visits for assessments during 1 to 12 months after treatment
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Using 3-D Virtual Lung Resection to Predict Lung Function After VATS Surgery for Non-Small Cell Lung Cancer
Developing Advanced 4D-MRI Imaging to Improve Radiation Therapy for Lung and Liver Cancer
Including Healthy Adult Volunteers for Imaging Research
Exploratory Study of 68Ga-SorB PETCT Imaging to Diagnose Sortilin-Positive Solid Tumors
A Clinical and Biological Database Study of Lung Cancer Patients Receiving Standard Treatments
Study on Causes and Impact of Vulnerability in Adult Men With Serious Diseases Including Cancer and Fractures
Community Health Approaches to Increase Lung Cancer Screening and Tobacco Treatment in Community Health Centers
Feasibility Study of MRI-Guided Stereotactic Ablative Radiotherapy for Abdominal and Lung Tumors
Phase 12 Study of 3H-10000 Infusion for Adults with Unresectable or Metastatic Lung or Stomach Cancer
AI-Based PETCT Imaging for Detailed Lung Cancer Subtyping and Genetic Mutation Prediction
A Study Testing Mobile Health Technology to Improve Lung Cancer Screening Among Adults Aged 50 to 77
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Personal innovative approach in radiation therapy of lung cancer- functional lung avoidance SPECT-guided (ASPECT) radiation therapy: a study protocol for phase II randomised double-blind clinical trial.